A highly sensitive protein-protein interaction assay based on Gaussia luciferase.
basic_science · Level V
Where this comes from
- Record sourced from PubMed, PMID 17099704.
- No licence information is recorded for this record.
- Because redistribution is not established, this page shows the abstract only. Follow the links below for the full text.
Abstract
Protein-fragment complementation assays (PCAs) provide a general strategy to study the dynamics of protein-protein interactions in vivo and in vitro. The full potential of PCA requires assays that are fully reversible and sensitive at subendogenous protein expression levels. We describe a new assay that meets these criteria, based on the Gaussia princeps luciferase enzyme, demonstrating chemical reversal, and induction and inhibition of a key interaction linking insulin and TGFbeta signaling.
Medical subject headings
- Biological Assay
- Copepoda
- Luciferases
- Luminescent Measurements
- Peptide Fragments
- Protein Interaction Mapping